MYC and medulloblastoma: Investigation into the possibility of delivering a retroviral vector capable of expressing MYC to induce medulloblastoma tumors similar to MYC expressing pediatric tumors demonstrated a low penetrance but metastasizing model when coupled with either Trp53 loss or Bcl-2 expression (40).